The 4th edition of the 3D Bioprinting Conference will take place on January 31, 2017, at MECC Maastricht, The Netherlands.
The conference content focuses on 3D bioprinting, the most disruptive application of 3D printing in the medical world, and latest developments and applications in the field. It is not a purely academic conference, but an innovative event bringing together brilliant minds and discoveries.
Fast facts about the importance of 3D Bioprinting
3D printing is becoming increasingly implemented in the operating room, with surgeons turning to the technology to create tailor-made implants for their patients. Several uses of the technology are already generating revenue as viable medical businesses, like dental applications, prosthetics and hearing devices.
The most disruptive application of 3D printing in the medical world might be bioprinting – the production of human organs for transplant or for body on a chip use. The technology involves the creation of replacement tissues and organs that are printed layer-by-layer into a three-dimensional structure.
This rapidly developing market raises many questions. Which technologies are developed yet? What are the costs of the production of bioprinted tissues and organs? Which effects does tissue engineering cause? Which markets are influenced by the innovative 3D printing technologies? And how quickly can those customized products be manufactured? The 3D Bioprinting Conference gives answers to these kinds of questions.
Who should attend?
The audience is a mix of academics, business, technology, regulation and creative, so the content will address both professionals and enthusiasts in the field. Accordingly, the conference is of interest for any person involved in health care innovation, from surgeon to biomedical engineer, from researcher to dentist and from hardware manufacturer to bio medical material researcher.
The conference is part of the 3D Medical Expo, an event that includes a two-day exhibition and three other conferences besides the 3D Bioprinting: